"A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle". M. F. Kircher, A. de la Zerda, J. V. Jokerst, C. L. Zavaleta, P. J. Kempen, E. Mittra, K. Pitter, R. Huang, C. Campos, F. Habte, R. Sinclair, C. W. Brennan, I. K. Mellinghoff, E. C. Holland, S. S. Gambhir. NATURE MEDICINE. In press. DOI: 10.1038/nm.2721
The difficulty in delineating brain tumor margins is a major obstacle in
the path toward better outcomes for patients with brain tumors. Current
imaging methods are often limited by inadequate sensitivity,
specificity and spatial resolution. Here we show that a unique
triple-modality magnetic resonance imaging–photoacoustic imaging–Raman
imaging nanoparticle (termed here MPR nanoparticle) can accurately help
delineate the margins of brain tumors in living mice both preoperatively
and intraoperatively. The MPRs were detected by all three modalities
with at least a picomolar sensitivity both in vitro and in living
mice. Intravenous injection of MPRs into glioblastoma-bearing mice led
to MPR accumulation and retention by the tumors, with no MPR
accumulation in the surrounding healthy tissue, allowing for a
noninvasive tumor delineation using all three modalities through the
intact skull. Raman imaging allowed for guidance of intraoperative tumor
resection, and a histological correlation validated that Raman imaging
was accurately delineating the brain tumor margins. This new
triple-modality–nanoparticle approach has promise for enabling more
accurate brain tumor imaging and resection.
No comments:
Post a Comment